Avingtrans Plc · LSE:AVG
Avingtrans — Investor Presentation (February 2024)
25 slides from Avingtrans's investor presentation, February 2024
Slide 1: Transforming Radiology
Transforming Radiology 1
Slide 2: Adaptix Update
Adaptix Update Stabilised company post-acquisition Distributors in place Refocussed business around 3 products: NDE, Vet, Ortho Production facility in Scotland progressing well Changed business plan toward a capital sales model Successful BSI regulatory audit with zero findings Commerc
Slide 3: Products and markets
Products and markets Non-Destructive Veterinary Orthopaedic General Dental Evaluation (NDE) Radiology Initial sales Initial sales FDA 510 (k) cleared Proof-of-principle Proof-of-principle STAGE 3
Slide 4: Large Total Addressable Market
Allowing us to build a meaningful business Large Total Addressable Market Cumulative TAM $12.8bn Portable Chest $4.5bn $8.3bn Dental Orthopedic $3.2bn Intra-oral $5.5bn Veterinary $2.8bn NDE $2.2bn $2.2bn $1.4bn 4
Slide 5: 5
5
Slide 6: The problem with current inspection
The problem with Current inspection CT ✕ Expensive ✕ Too slow ✕ Can’t fit many large parts ✕ Unsuitable for Metal Additive Manufacture (MAM) ✕ Requires skilled inspectors, who are scarce ✕ Struggles with complex composites ✕ Huge cost, time and material waste from downstream, deficient inspection Ul
Slide 7: The AdaptixNDE Solution
Introducing The AdaptixNDE Solution Fast Economical Unique upstream manufacturing Enabling in-line inspection of inspection saving >60% composites waste/energy/cost/time Uniquely inspecting metal Half the price of traditional 3D X- additive parts at the rate of ray manufacture Comprehensive
Slide 8: NDE Update
Update NDE Featured in the UK Government Advanced Manufacturing Plan Substantially progressed the products • Improved imaging capability Approved under HSE’s new rules Repeat business from Aerospace sector Aerospace prime ‘excited about Adaptix NDE’ What our users say… “ Azego TS LTD, a le
Slide 9: VET
VET 9
Slide 10: The problem with current Veterinary Imaging
The problem with current Veterinary Imaging 2D ✕ Poor 2D images ✕ Unnecessary referrals to CT (high dose) & MRI ✕ Limited space ✕ Plates are bulky (DR) ✕ Advanced training required ✕ Lack of mobility ✕ High level of expertise required ✕ Time consuming (Intra-oral) ✕ Extended workflows (with CT denta
Slide 11: Introducing the Adaptix 3D X-ray Small Animal
Introducing the Adaptix 3D X-ray Small Animal 3D More revenue First-line diagnostics Lower total cost for vets and patients Superior image quality Reduces the need for referrals Low dose Small & easy to use Reduces dose to patient and clinicians Avoids space issues Compact Connected
Slide 12: VET Update
Update VET Major hardware upgrade to system Service and support function now established as part of commercialisation Major software updates aiding useability US Distributor now in place First commercial sale under capital model • Demonstration unit with Distributor Evaluation units at s
Slide 13: Ortho
Ortho Ortho 13
Slide 14: The problem with Ortho current imaging modalities
The problem with Ortho 2D ✕ Poor 2D images Current imaging ✕ Unnecessary referrals to modalities CT (high dose) & MRI ✕ High infrastructure & maintenance costs ✕ Long & expensive installation CT ✕ Dedicated rooms ✕ Expensive ✕ High infrastructure & maintenance costs ✕ High radiation dose ✕ Requires
Slide 15: The Adaptix Ortho Solution
Introducing The Adaptix Ortho Solution 3D Small & easy to use First-line diagnostics Portable Superior image quality Avoids space issues Improves diagnostic clarity Point-of-care deployment Single phase electricity Low dose Reduces dose to patient & clinicians No shielded room requ
Slide 16: PY Nee
co PY Nee i 7 Lateral Elbow . . ze Lpenor 3 moc
Slide 17: Ortho Update
Update Ortho FDA Clearance Setting up manufacturing line at Scotland facility • Robust supply chain (including fab.) progressing well Potential demand for the product larger than anticipated US distributor in place What potential users said … “ I wish all my clinics had “ I have a long-held
Slide 18: In summary
In summary Stability since Avingtrans purchase in Summer 2023 Good progress establishing manufacturing capability in "Silicon Glen" Scotland Refocus on core goals now generating gains US market distribution agreement Significant progress made in commercialisation of Vet and NDE products
Slide 19: Appendix
eccce eecee ecece eecee eccce Appendix
Slide 20: The Adaptix Ortho Solution
Introducing The Adaptix Ortho Solution 3D Small & easy to use First-line diagnostics Portable Superior image quality Avoids space issues Improves diagnostic clarity Point-of-care deployment Single phase electricity Low dose Reduces dose to patient & clinicians No shielded room requ
Slide 21: Low Dose
Transforming Radiology Low Dose Low dose An Adaptix ortho system delivers an equivalent dose as a standard 2D x- ray system but delivers Effective dose range from an 30-50x image output Adaptix Ortho scan is less than 0.001mSv (similar to a standard 2D x-ray). No shielded room required. Clinicia
Slide 22: Affordable
Transforming Radiology Affordable ACCESSIBLE Desktop and mobile applications available No additional infrastructure required Driving down cost of 1st line diagnostic Facilitates more widespread deployment 22
Slide 23: Small and easy to use
Transforming Radiology Small and easy to use Compact unit that is completely portable - Deploy anywhere there is power. 15kg Avoids space issues – with a small footprint and lightweight The C-arm unit weighs SINGLE PIVOT design, the Adaptix Ortho solution easily fits into small spaces. only 33lb
Slide 24: Connected
Transforming Radiology Connected ACCESSIBLE Desktop and mobile applications available MOBILE Putting patient data in your hands CONNECTED Real-time results 24
Slide 25: Revolutionary
Adaptix is disrupting the imaging market Revolutionary NDE VET ORTHO 25